ALXN
Grantham, Mayo, Van Otterloo & Co (GMO)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-528,033
| Closed | -$97M | – | 790 |
|
|
2021
Q2 | $97M | Sell |
528,033
-141,290
| -21% | -$26M | 0.48% | 45 |
|
|
2021
Q1 | $102M | Buy |
669,323
+397,440
| +146% | +$60.8M | 0.56% | 41 |
|
|
2020
Q4 | $42.5M | Buy |
+271,883
| New | +$42.5M | 0.26% | 60 |
|
|
2013
Q3 | – | Sell |
-69,727
| Closed | -$6.43M | – | 704 |
|
|
2013
Q2 | $6.43M | Buy |
+69,727
| New | +$6.43M | 0.02% | 259 |
|